A comprehensive review published in Brain Medicine illuminates the intricate connections between gut microbiota and sleep regulation, establishing the microbiota-gut-brain axis as a critical pathway ...
A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and ...
During a live event, Randy F. Sweis, MD, and participants discussed treating non–clear cell renal cell carcinoma based on ...
Total 3Q 2025 net product revenue of $171.0 million, representing 63% year-over-year growthAUVELITY® 3Q 2025 net product sales of $136.1 million, ...
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback